Peer-reviewedCC BY 4.0Frontiers in Public Health
Beyond medication: rethinking postpartum obesity management in the era of increasing GLP-1 receptor agonist use
Related
- Analyzing postpartum patients’ attitudes towards medication for weight management: a mixed-methods analysis
- Health prevention research in France: Increasing investment is a priority, rethinking targets is equally crucial
- No Field for Lactation: Inferring Lactation Status From US Commercial Claims to Describe Postpartum Medication Dispensing
- Medication-related knowledge and behavior profiles are generally favorable, but counseling needs remain among pregnant and postpartum women in Taiyuan, China: a cross-sectional study
- Rethinking nasopharyngeal carcinoma management: toward a low-toxicity, highly effective regimen with favorable tolerability and quality of life
BibTeX
@article{achickmuyu2026beyond,
title = {{Beyond medication: rethinking postpartum obesity management in the era of increasing GLP-1 receptor agonist use}},
author = {Verena Atud Achick-Muyu},
journal = {Frontiers in Public Health},
year = {2026},
month = nov,
doi = {10.3389/fpubh.2026.1895107},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1895107},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond medication: rethinking postpartum obesity management in the era of increasing GLP-1 receptor agonist use
AU - Verena Atud Achick-Muyu
PY - 2026
DA - 2026/11/06
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1895107
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1895107
SN - 2296-2565
ER -